Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 177-181

  Hayakawa, Takanori ^a,b   Chang, Michael C J ^a   Bell, Jane M ^a   Seeman, Ruth ^a   Rapoport, Stanley I ^a   Appel, Nathan M ^a,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Div of Appl Pharmacology Research   (United States)

Author keywords

6 Hydroxydopamine; Arachidonic acid; Autoradiography; Basal ganglia; Brain metabolism; Fatty acid; Functional brain imaging; Parkinson's disease; Phospholipase A2

Indexed keywords

ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; BRAIN METABOLISM; FATTY ACID METABOLISM; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BASAL GANGLIA; BRAIN; BRAIN MAPPING; CAUDATE NUCLEUS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FATTY ACIDS; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; MALE; PARKINSON DISEASE, SECONDARY; PHOSPHOLIPASES A; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0032487663     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00751-3     Document Type: Article

References (25)

1. Appel N.M., Rapoport S.I., O'Callaghan J.P., Bell J.M., Freed L.M. Sequelae of parenteral domoic acid administration in rats: comparison of effects on different metabolic markers in brain. Brain Res. 754:1997;55-64.
2. A. Björklund, O. Lindvall, Dopamine-containing systems in the CNS, in: Björklund A., Hökfelt T., (Eds.), Handbook of Chemical Neuroanatomy, Vol. 2, Elsevier, Amsterdam, 1984, pp. 55-122.
3. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1996;3177-3188.
4. Breese G.R., Traylor T.D. Depletion of brain noradrenalin and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42:1971;88-99.
5. 11C ]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography Brain Res. 755:1997;74-83.
6. DeGeorge J.J., Nariai T., Yamazaki S., Williams W.M., Rapoport S.I. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanaesthetized rats. J. Neurochem. 56:1991;352-355.
7. 14C ]arachidonate to examine regional brain lipid metabolism in unanesthetized rats J. Neurosci Res. 24:1989;413-423.
8. Gerfen C.R., McGinty J.F., Young III W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
9. Gerlach M., Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 103:1996;987-1041.
10. 2 inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat, Neurochem. Res., in press.
11. 3H ]arachidonic acid from blood into brain synaptosomal fractions before and after cholinergic stimulation J. Neurochem. 67:1996;822-829.
12. 2 dopamine receptors mediate the potentiation of arachidonic acid release in chinese hamster ovary cells. Mol. Pharmacol. 39:1991;364-369.
13. H. Narabayashi, T. Nagatsu, N. Yanagisawa, Y. Misono, (Eds.), Parkinson's Disease from Basic Research to Treatment, Advances in Neurology, Vol. 60, Raven, New York, 1993, 773 pp.
14. 14C ]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis Brain Res. 559:1991;1-9.
15. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, 1996.
16. 2 receptor synergism. Nature. 353:1991;161-167.
17. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Rev. 17:1992;187-214.
18. Sagar S.M., Snodgrass S.R. Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the rat. Brain Res. 185:1980;335-348.
19. Sokoloff L. Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. J. Cereb. Blood Flow Metab. 1:1981;7-36.
20. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
21. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;69-93.
22. 2. J. Neurochem. 64:1995;2765-2772.
23. Wakabayashi S., Freed L.M., Chang M., Rapoport S.I. In vivo imaging of brain incorporation of fatty acids and 2-deoxy-D-glucose demonstrates functional and structural neuroplastic effects of chronic unilateral orbital unilateral visual deprivation in rats. Brain Res. 679:1995;110-122.
24. Wakabayashi S., Freed L.M., Bell J.M., Rapoport S.I. In vivo cerebral incorporation of radiolabeled fatty acids after acute unilateral orbital enucleation in adult hooded Long-Evans rats. J. Cereb. Blood Flow Metab. 14:1994;312-323.
25. Wooten G.F., Collins R.C. Metabolic effects of unilateral lesion of the substantia nigra. J Neurosci. 1:1981;285-291.